Literature DB >> 11953738

Efficacy of latex avoidance for primary prevention of latex sensitization in children with spina bifida.

Antonio Nieto1, Angel Mazón, Rafael Pamies, Amparo Lanuza, Alberto Muñoz, Francisco Estornell, Fernando García-Ibarra.   

Abstract

Over 6 years, the prevalence of latex sensitization fell from 4/15 (26.7%) to 1/22 (4.5%) in children with spina bifida treated in a latex-free environment from birth compared with historic controls. These precautions appear to be efficacious for the primary prevention of latex sensitization.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11953738     DOI： 10.1067/mpd.2002.122732

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  4 in total

Review 1.  Prevention of anaphylactic reactions to anaesthetic drugs.

Authors:  Malcolm M Fisher; Gordon S Doig
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Latex sensitisation and allergy in children with myelomeningocele.

Authors:  C Rendeli; E Nucera; E Ausili; F Tabacco; C Roncallo; E Pollastrini; M Scorzoni; D Schiavino; M Caldarelli; D Pietrini; G Patriarca
Journal:  Childs Nerv Syst       Date:  2005-02-10       Impact factor: 1.475

3.  Actual therapeutic management of allergic and hyperreactive nasal disorders.

Authors:  Claudia Rudack
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2004-12-28

4.  Latex allergy guidelines for people with spina bifida.

Authors:  Veronica Meneses; Sarah Parenti; Heather Burns; Richard Adams
Journal:  J Pediatr Rehabil Med       Date:  2020
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.